Collaborate Disseminate
New real-world data from the UK Health Security Agency has shown a third COVID-19 vaccine dose significantly boosts protection against symptomatic disease. The findings indicate a third dose will be vital in pushing back the growing wave of SARS-CoV-2 … Continue reading Real-world data finds 3rd COVID vaccine dose greatly boosts protection
A new study in The Lancet is offering the first peer-reviewed and published data on the efficacy of Covaxin, a COVID-19 vaccine developed in India. The vaccine was found to be 77.8 percent effective at preventing symptomatic COVID-19 in a large Phase 3… Continue reading India’s Covaxin COVID-19 vaccine 77.8% effective, Lancet study finds
Researchers at the Yale School of Medicine have developed a new kind of COVID-19 treatment designed to stimulate the body’s immune defenses and fight off a coronavirus infection at its earliest stages. In preclinical animal tests an experimental RNA mo… Continue reading Experimental RNA therapy harnesses immune system to fight COVID-19
A new study, published in the journal Nature, has found a key fatty acid found in palm oil can promote cancer metastasis in mice. The research, which does not claim dietary palm oil has cancer-causing properties in humans, could lead to new therapies t… Continue reading Fatty acid in palm oil linked to cancer metastasis
A new study is proposing blood levels of a specific protein may serve as a useful predictor of type 2 diabetes developing up to two decades before any symptoms appear. The findings indicate a diagnostic blood test could be deployed to offer people a wa… Continue reading Blood biomarker predicts type 2 diabetes risk up to 19 years before onset
A new survey from the Kaiser Family Foundation (KFF) has found 78 percent of Americans believe at least one piece of COVID-19 misinformation. The nonpartisan survey also found more than one third of those polled believe the US government is exaggeratin… Continue reading Majority of Americans believe at least some form of COVID misinformation
UK researchers investigating a cohort of healthcare workers with a strange pre-existing resistance to SARS-CoV-2 infection have discovered a new antigen target for the next generation of COVID-19 vaccines. The researchers speculate the next wave of vac… Continue reading Next-gen supercharged COVID-19 vaccines may also target the common cold
Could the future of rheumatoid arthritis treatment be a small implant designed to deliver bursts of electrical stimulation to a key nerve that can regulate the body’s inflammatory reflex? A flurry of research around the world is investigating this comp… Continue reading How tiny electrical implants could treat rheumatoid arthritis
Early data from the largest trial to date testing psilocybin therapy for depression indicates the psychedelic treatment may be somewhat effective at reducing symptom severity. However, concerns over some adverse effects indicate there is more work to b… Continue reading Largest psychedelic therapy trial to date delivers mixed results
A massive study comparing the real-world effectiveness of three COVID-19 vaccines over eight months has detected protection from infection may decline but protection from death holds strong. Tracking nearly 800,000 US Veterans, the study found Johnson … Continue reading Study compares decline in effectiveness of 3 COVID vaccines over time